What clinical studies have been done to show the efficacy of Argatroban?
Two clinical studies, ARG-911 and ARG-915, form the basis of the conclusion that Argatroban is well tolerated and an effective treatment for heparin-induced thrombocytopenia (HIT) with or without thrombosis. These studies were comparable with regard to study design, study objectives, and dosing regimens, as well as study outline, conduct, and monitoring. Click here to learn more.
